Longitudinal Effect of Guselkumab on Biomarkers of Inflammation and Cardiovascular Risk in Bionaive Patients with Active Psoriatic Arthritis and High Systemic Inflammatory Burden: Post-hoc Analysis of a Phase 3, Randomized, Double-blind, Placebo-Controlled Study

被引：0

作者：

Kavanaugh, Arthur ^{[1
]}

Soriano, Enrique ^{[2
,3
]}

Dutz, Jan ^{[4
]}

Selmi, Carlo ^{[5
]}

Rampakakis, Emmanouil ^{[6
]}

Shiff, Natalie ^{[7
]}

Nantel, Francois ^{[8
]}

Lavie, Frederic ^{[9
]}

Coates, Laura ^{[10
]}

机构：

[1] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, La Jolla, CA USA

[2] Hosp Italiano Buenos Aires, Internal Med Serv, Rheumatol Sect, Buenos Aires, DF, Argentina

[3] Univ Inst Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina

[4] Vancouver Gen Hosp, Dept Dermatol & Skin Sci, Vancouver, BC, Canada

[5] Humanitas Univ, Humanitas Res Hosp Internal Med, Rheumatol & Clin Immunol, Rozzano, Italy

[6] McGill Univ, JSS Med Res, Sci Affairs, Dept Pediat, Montreal, PQ, Canada

[7] Univ Saskatchewan, Immunol, Janssen Sci Affairs LLC Adjunct, Horsham, PA USA

[8] Nantel Medsci Consult, Montreal, PQ, Canada

[9] Janssen Pharmaceut Companies Johnson & Johnson, Paris, France

[10] Univ Oxford, Oxford, England

来源：

ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷

关键词：

BIOLOGIC-NAIVE;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2238

引用

页码：4421 / 4424

页数：4

共 50 条

[41] Post-inflammatory and Degenerative Changes in Patients with Psoriatic Arthritis and Axial Manifestations: Post-hoc Analysis from a Double-blind, Randomized, Phase 3b Trial
Baraliakos, Xenofon
Pournara, Effie
Coates, Laura
Navarro-Compan, Victoria
White, Roisin
Schulz, Barbara
Landewe, Robert
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 4071 - 4073
[42] Efficacy of novel β3-adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post-hoc analysis of a randomized, double-blind, placebo-controlled phase 3 study
Yoshida, Masaki
Takeda, Masayuki
Gotoh, Momokazu
Yokoyama, Osamu
Kakizaki, Hidehiro
Takahashi, Satoru
Masumori, Naoya
Nagai, Shinji
Hashimoto, Keita
Minemura, Kazuyoshi
INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 (03) : 369 - 375
[43] LONG-TERM EFFICACY OF GUSELKUMAB IN FATIGUE AND IDENTIFICATION OF EARLY TREATMENT TARGETS: POST HOC ANALYSIS THROUGH 2 YEARS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY CONDUCTED IN BIOLOGIC-NAIVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
Gladman, D. D.
Starr, M.
Ranza, R.
Bravo Perdomo, A. M.
Strauss, M.
Shawi, M.
Han, C.
Rampakakis, E.
Ostor, A. Andrew
Mease, P. J.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1765 - 1765
[44] Long-term Efficacy of Guselkumab in Fatigue and Identification of Early Treatment Targets: Post Hoc Analysis Through 2 Years of a Phase 3, Randomized, Double-blind, Placebo-controlled Study Conducted in Biologic-naive Patients with Active Psoriatic Arthritis
Gladman, Dafna
Starr, Michael
Ranza, Roberto
Perdomo, Ana-Maria Bravo
Strauss, Marcie
Shawi, May
Han, Chenglong
Rampakakis, Emmanouil
Ostor, Andrew
Mease, Philip J.
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4175 - 4178
[45] Re: Cardiovascular Safety of Vibegron, a New β3-Adrenoceptor Agonist, in Older Patients with Overactive Bladder: Post-Hoc Analysis of a Randomized, Placebo-Controlled, Double-Blind Comparative Phase 3 Study
不详
JOURNAL OF UROLOGY, 2022, 207 (02): : 441 - 441
[46] Long-term Efficacy of Guselkumab in Fatigue and Identification of Early Treatment Targets: Post Hoc Analysis Through 2 Years of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Conducted in Biologic-Naive Patients With Active Psoriatic Arthritis
Gladman, Dafna
Starr, Michael
Ranza, Roberto
Perdomo, Ana
Strauss, Marcie
Shawi, May
Han, Chenglong
Rampakakis, Emmanouil
Ostor, Andrew
Mease, Philip
JOURNAL OF RHEUMATOLOGY, 2023, 50 (07) : 79 - 79
[47] Prevention of joint destruction by tacrolimus in patients with early rheumatoid arthritis: a post hoc analysis of a double-blind, randomized, placebo-controlled study
Tanaka, Yoshiya
Kawai, Shinichi
Takeuchi, Tsutomu
Yamamoto, Kazuhiko
Miyasaka, Nobuyuki
MODERN RHEUMATOLOGY, 2013, 23 (06) : 1045 - 1052
[48] Sex-Related Differences in Baseline Patient and Disease Characteristics: Post Hoc Analyses of Three Phase 3, Randomized, Double-blind, Placebo-Controlled Studies in Patients with Active Psoriatic Arthritis
Coates, Laura
Selmi, Carlo
Mease, Philip
Ogdie, Alexis
Nantel, Francois
Lavie, Frederic
Sharaf, Mohamed
Adelakun, Oyediran
Rampakakis, Emmanouil
Vegas, Laura Pina
Eder, Lihi
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1198 - 1200
[49] Secukinumab improves active psoriatic arthritis and inhibits radiographic progression: Results of a phase 3 randomized, multicenter, double-blind, placebo-controlled study
Mease, P.
McInnes, I. B.
Kirkham, B.
Kavanaugh, A.
Rahman, P.
Van Der Heijde, D.
Landewe, R.
Nash, P.
Pricop, L.
Yuan, J.
Richards, H.
Mpofu, S.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S29 - S29
[50] EFFICACY AND SAFETY RESULTS OF GUSELKUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OVER 56 WEEKS FROM A PHASE 2A, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Deodhar, A.
Gottlieb, A. B.
Boehricke, W-H.
Dong, B.
Wang, Y.
Zhuang, Y.
Barchuk, W.
Xu, X. L.
Hsia, E.
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 201 - 201

← 1 2 3 4 5 →